D. Basset, ;. Bastien, ;. Brouqui-;-m-cividin, ;. Delaunay, ;. Delhaes et al., Hôpital d'Instruction des Armées Saint-Anne, Toulon), A Genin (Centre Hospitalier du Pays d' Aix, A Mottard, 2015.

, Geneva: World Health Organization, 2018.

F. Nosten and N. J. White, Artemisinin-based combination treatment of falciparum malaria, Am J Trop Med Hyg, vol.77, pp.181-92, 2007.

A. M. Dondorp, F. Nosten, P. Yi, D. Das, A. P. Phyo et al., Artemisinin resistance in Plasmodium falciparum malaria, N Engl J Med, vol.361, pp.455-67, 2009.

E. A. Ashley, M. Dhorda, R. M. Fairhurst, C. Amaratunga, P. Lim et al., Spread of artemisinin resistance in Plasmodium falciparum malaria, N Engl J Med, vol.371, pp.411-434, 2015.

H. C. Slater, J. Griffin, A. Ghani, and L. Okell, Assessing the potential impact of artemisinin and partner drug resistance in sub-Saharan Africa, Malar J, vol.15, p.10, 2016.

C. M. Parobek, J. B. Parr, N. F. Brazeau, C. Lon, S. Chaorattanakawee et al., Partner-drug resistance and population substructuring of artemisininresistant Plasmodium falciparum in Cambodia, Genome Biol Evol, vol.9, pp.1673-86, 2017.

F. Ariey, B. Witkowski, C. Amaratunga, J. Beghain, A. Langlois et al., A molecular marker of artemisinin-resistant Plasmodium falciparum malaria, Nature, vol.505, pp.50-55, 2014.
URL : https://hal.archives-ouvertes.fr/pasteur-00921203

D. Ménard, N. Khim, J. Beghain, A. A. Adegnika, M. Shafiul-alam et al., A worldwide map of Plasmodium falciparum K13-propeller polymorphisms, N Engl J Med, vol.374, pp.2453-64, 2016.

A. Mukherjee, S. Bopp, P. Magistrado, W. Wong, R. Daniels et al., Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia, Malar J, vol.16, p.195, 2017.

M. M. Plucinski, E. Talundzic, L. Morton, P. R. Dimbu, A. P. Macaia et al., Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire, Antimicrob Agents Chemother, vol.59, pp.437-480, 2015.

B. Dieye, M. Affara, L. Sangare, F. Joof, Y. D. Ndiaye et al., West Africa international centers of excellence for malaria research: drug resistance patterns to artemether-lumefantrine in Senegal, Mali, and the Gambia, Am J Trop Med Hyg, vol.95, pp.1054-60, 2016.

M. M. Plucinski, P. R. Dimbu, A. P. Macaia, C. M. Ferreira, C. Samutondo et al., Efficacy of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, Malar J, vol.16, p.62, 2015.

C. J. Sutherland, P. Lansdell, M. Sanders, J. Muwanguzi, D. A. Van-schalkwyk et al., Pfk13-independent treatment failure in four imported cases of Plasmodium falciparum malaria treated with artemetherlumefantrine in the United Kingdom, Antimicrob Agents Chemother, vol.61, pp.2382-2398, 2017.

M. Madamet, M. B. Kounta, K. A. Wade, G. Lo, S. Diawara et al., Absence of association between polymorphisms in the K13 gene and the presence of Plasmodium falciparum parasites at day 3 after treatment with artemisinin derivatives in Senegal, Int J Antimicrob Agents, vol.49, pp.754-760, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01573744

A. R. Demas, A. I. Sharma, W. Wong, A. M. Early, S. Redmond et al., Mutations in Plasmodium falciparum actin-binding protein coronin confer reduced artemisinin susceptibility, Proc Nath Acad Sci USA, vol.115, pp.12799-804, 2018.

G. Henriques, R. L. Hallett, K. B. Beshir, N. B. Gadalla, R. E. Johnson et al., Directional selection at the pfmdr1, pfcrt, pfubp1, and pfap2mu loci of Plasmodium falciparum in Kenyan children treated with ACT, J Infect Dis, vol.210, pp.2001-2009, 2014.

M. D. Spring, J. T. Lin, J. E. Manning, P. Vanachayangkul, S. Somethy et al., Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study, Lancet Infect Dis, vol.15, pp.683-91, 2015.

C. Amaratunga, P. Lim, S. Suon, S. Sreng, S. Mao et al., Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study, Lancet Infect Dis, vol.16, pp.357-65, 2016.

B. Q. Phuc, C. Rasmussen, T. T. Duong, L. T. Dong, M. A. Loi et al., Treatment failure of dihydroartemisinin/piperaquine for Plasmodium falciparum malaria, Emerg Infect Dis, vol.23, pp.715-722, 2017.

N. V. Thanh, N. Thuy-nhien, N. T. Tuyen, N. T. Tong, N. T. Nha-ca et al., Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam, Malar J, vol.16, p.27, 2017.

B. Witkowski, V. Duru, N. Khim, L. S. Ross, B. Saintpierre et al., A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study, Lancet Infect Dis, vol.17, pp.174-83, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-01400955

R. Amato, P. Lim, O. Miotto, C. Amaratunga, D. Dek et al., Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study, Lancet Infect Dis, vol.17, pp.164-73, 2017.

M. D. Conrad, D. Mota, M. Foster, S. Tukwasibwe, J. Legac et al., Impact of intermittent preventive treatment during pregnancy on Plasmodium falciparum drug resistance-mediating polymorphisms in Uganda, J Infect Dis, vol.216, pp.1008-1025, 2017.

S. A. Rasmussen, F. G. Ceja, M. D. Conrad, P. K. Tumwebaze, O. Byaruhanga et al., Changing antimalarial drug sensitivities in Uganda. Antimicrob Agents Chemother, vol.61, pp.1516-1533, 2017.

M. A. Kakolwa, M. K. Mahende, D. S. Ishengoma, C. I. Mandara, B. Ngasala et al., Efficacy and safety of artemisinin-based combination therapy and molecular markers for artemisinin and piperaquine resistance in Mailand Tanzania, Malar J, vol.17, p.369, 2018.

M. G. Robert, F. Tsombeng, F. Gendrot, M. Mosnier, J. Amalvict et al., Absence of high level of duplication of the plasmepsin 2 gene in Africa, Antimicrob Agents Chemother, vol.62, pp.374-392, 2018.

M. G. Robert, F. Tsombeng, F. Gendrot, M. Diawara, S. Madamet et al., Baseline ex vivo and molecular responses of Plasmodium falciparum isolates to piperaquine before implementation of dihydroartemisinin-piperaquine in Senegal, Antimicrob Agents Chemother, vol.63, pp.2445-2463, 2019.

L. S. Ross, S. K. Dhingra, S. Mok, T. Yeo, K. J. Wicht et al., Emerging Southeast Asian Pfcrt mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine, Nat Commun, vol.9, p.3314, 2018.

D. A. Fidock, T. Nomura, A. K. Talley, R. A. Cooper, S. M. Dzekunov et al., Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance, Mol Cell, vol.6, pp.861-71, 2000.

B. Pradines, V. Parquet, and E. Orlandi-pradines, ABC transporters in Plasmodium and their involvement in resistance to antimalarial drugs, pp.113-141, 2009.

M. I. Veiga, S. K. Dhingra, P. P. Henrich, J. Straimer, N. Gnägig et al., Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies, Nat Commun, vol.7, p.11553, 2016.

A. B. Sidhu, S. G. Valderramos, and D. A. Fidock, Pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum, Mol Microbiol, vol.57, pp.13-926, 2005.

R. N. Price, A. C. Uhlemann, A. Brockman, R. Mcgready, A. E. Phaipun et al., Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number, Lancet, vol.364, pp.438-485, 2004.

J. I. Nankabirwa, M. D. Conrad, J. Legac, S. Tukwasibwe, P. Tumwebaze et al., Intermittent preventive treatment with dihydroartemisinin-piperaquine in Ugandan schoolchildren selects for Plasmodium falciparum transporter polymorphisms that modify drug sensitivity, Antimicrob Agents Chemother, vol.60, pp.5649-54, 2016.

R. E. Martin, R. I. Henry, J. L. Abbey, J. D. Clements, and K. Kirk, The 'permeome' of malaria parasite: an overview of the membrane transport protein of Plasmodium falciparum, Genome Biol, vol.6, p.26, 2015.

N. Yan, Structural biology of the major facilitator superfamily transporters, Annu Rev Biophys, vol.44, pp.257-83, 2015.

M. Y. Lim, G. Lamonte, M. C. Lee, C. Reimer, B. H. Tan et al., UDPgalactose and acetyl-CoA transporters as Plasmodium multidrug resistance genes, Nat Microbiol, vol.19, p.16166, 2016.

K. L. Kuhen, A. K. Chatterjee, M. Rottmann, K. Gagaring, R. Borboa et al., KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission, Antimicrob Agents Chemother, vol.58, pp.5060-5067, 2014.

N. J. White, T. T. Duong, C. Uthaisin, F. Nosten, A. P. Phyo et al., Antimalarial activity of KAF156 in falciparum and vivax malaria, N Engl J Med, vol.375, pp.1152-60, 2016.

S. Meister, D. M. Plouffe, K. L. Kuhen, G. Bonamy, T. Wu et al., Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery, Science, vol.334, pp.1372-1379, 2011.

G. Lamonte, M. Y. Lim, M. Wree, C. Reimer, M. Nachon et al., Mutations in the Plasmodium falciparum cyclic amine resistance locus (PfCARL) confer multidrug resistance, Mbio, vol.7, pp.696-712, 2016.

P. A. Magistrado, V. C. Corey, A. K. Lukens, G. Lamonte, E. Sasaki et al., Plasmodium falciparum cyclic amine resistance locus (PfCARL), a resistance mechanism for two distinct compounds classes, ASC Infect Dis, vol.2, pp.816-842, 2016.

M. C. Jonikas, S. R. Collins, V. Denic, E. Oh, E. M. Quan et al., Comprehensive characterization of genes required for protein folding in the endoplasmic reticulum, Science, vol.323, pp.1693-1700, 2009.

A. Boussaroque, B. Fall, M. Madamet, K. A. Wade, M. Fall et al., Prevalence of anti-malarial resistance gens in Dakar, Senegal from 2013 to, Malar J, vol.15, p.347, 2014.

B. Fall, M. Madamet, C. Camara, R. Amalvict, M. Fall et al., Plasmodium falciparum in vitro resistance to monodesethylamodiaquine, Emerg Infect Dis, vol.22, pp.841-846, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01521245

S. Diawara, M. Madamet, M. B. Kounta, G. Lo, K. A. Wade et al., Confirmation of Plasmodium falciparum in vitro resistance to monodesethylamodiaquine and chloroquine in Dakar, Malar J, vol.16, p.118, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01521245

N. Wurtz, B. Fall, K. Bui, A. Pascual, M. Fall et al., Pfhrp2 and pfhrp3 polymorphisms in Plasmodium falciparum isolates from Dakar, Senegal: impact on rapid malaria diagnostic tests, Malar J, vol.12, p.34, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00787797

A. Pascual, L. K. Basco, R. Amalvict, D. Travers, C. Rogier et al., Use of the atmospheric generators for capnophilic bacteria Genbag-CO 2 for the evaluation of in vitro Plasmodium falciparum susceptibility to standard anti-malarial drugs, Malar J, vol.10, issue.8, 2011.

B. Pradines, L. Bertaux, C. Pomares, P. Delaunay, and P. Marty, Reduced in vitro susceptibility to artemisinin derivatives associated with multi-resistance in a traveler returning from South-East Asia, Malar J, vol.10, p.268, 2011.

A. Pascual, M. Madamet, S. Briolant, T. Gaillard, R. Amalvict et al., Multinormal in vitro distribution of Plasmodium falciparum susceptibility to piperaquine and pyronaridine, Malar J, vol.14, p.49, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01221323

B. Fall, C. Camara, M. Fall, A. Nakoulima, P. Dionne et al., Plasmodium falciparum susceptibility to standard and potential anti-malarial drugs in Dakar, Senegal, during the 2013-2014 malaria season, Malar J, vol.14, p.60, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01220028

H. Bogreau, F. Renaud, H. Bouchiba, P. Durand, S. B. Assi et al., Genetic diversity and structure of African Plasmodium falciparum populations in urban and rural areas, Am J Trop Med Hyg, vol.74, pp.953-962, 2006.

M. Henry, I. Diallo, J. Bordes, S. Ka, B. Pradines et al., Urban malaria in Dakar, Senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates, Am J Trop Med Hyg, vol.75, pp.146-51, 2006.

V. Duru, N. Khim, R. Leang, S. Kim, A. Domergue et al., Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations, BMC Med, vol.13, p.305, 2015.

L. K. Basco, Field application of in vitro assays for the sensitivity of human malaria parasites to antimalarial drugs. Geneva: World health Organization, pp.69-71, 2007.

?. Fast, convenient online submission ? thorough peer review by experienced researchers in your field ? rapid publication on acceptance ? support for research data, including large and complex data types ? gold Open Access which fosters wider collaboration and increased citations maximum visibility for your research: over 100M website views per year

, Ready to submit your research ? Choose BMC and benefit from

B. Pradines, A. Spiegel, C. Rogier, A. Tall, J. Mosnier et al., Antibiotics for prophylaxis of Plasmodium falciparum infections: in vitro activity of doxycycline against Senegalese isolates, Am J Trop Med Hyg, vol.62, pp.82-87, 2000.

B. Pradines, C. Rogier, T. Fusai, J. Mosnier, W. Daries et al., In vitro activities of antibiotics against Plasmodium falciparum are inhibited by iron, Antimicrob Agents Chemother, vol.45, pp.1746-50, 2001.

S. Briolant, P. Parola, T. Fusai, M. Madamet-torrentino, E. Baret et al., Influence of oxygen on asexual blood cycle and susceptibilily of Plasmodium falciparum to chloroquine: requirement of a standardized in vitro assay, Malar J, vol.6, p.44, 2007.

S. Wein, M. Maynadier, T. Van-ba, C. Cerdan, R. Peyrottes et al., Reliability of antimalarial sensitivity tests depends on drug mechanism of action, J Clin Microbiol, vol.48, pp.1651-60, 2010.

, Publisher's Note

, Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations